We evaluated the genetic diversity in the VP1/VP2 gene of CPV type 2b isolates from symptomatic dogs in Brazil. A total of 21 isolates collected from 1990 through 1995 previously typed as CPV2b by PCR assay were studied. Overall we found a high degree of similarity among sequences from different CPV clinical isolates collected. Genetic analysis of this selected region gave no indication of a specific Brazilian parvovirus lineage.
Canine parvovirus (CPV), a new pathogen of dogs, was first isolated in 1978 in the USA (1) . Analysis of CPV isolates in the USA by monoclonal antibodies and restriction enzymes have shown that after the first emergence of CPV (CPV-2) it evolved to give rise to new antigenic types, which were designated CPV type-2a and CPV type-2b (6, 8) . The same pattern of spread of CPV-2, and the emergence and subsequent replacement by the new antigenic strains were also shown by antigenic and genetic analysis of isolates from various parts of the world, although there are various proportions of the CPV2a and CPV-2b strains (2, 4, 5, (8) (9) (10) (11) (12) 14) . DNA sequence comparisons among CPV antigenic types have shown nucleotide substitutions in the VP1/VP2 capsid protein gene. Molecular structure examination of the CPV showed that most of these amino acid differences are exposed on the surface of the capsid, revealing the correlation of these residues with immunity escape, host range, and haemagglutination properties of these viruses. Some of the surface changes may also represent a further adaptation of CPV for optimal replication in an spread among dogs (6, 13) .
In this study we evaluated the genetic diversity in the VP1/ VP2 gene of CPV type 2b isolates from clinically ill dogs, in São Paulo, Brazil.
A total of 21 isolates collected from 1990 through 1995 previously typed as CPV2b by PCR assay (3,9) were studied. PCR was used to amplify a 427 base region of VP1/VP2 gene and this product was sequenced. The location of the oligonucleotide primer pair, called Pb sense (+) and Pb antisense (-) in the CPV genome and nucleotide sequence are shown in Fig. 1 .
The products of the PCR assay were electrophoresed on 1.2% agarose gel, and after DNA elution using the Concert Gel Extraction Systems (GibcoBRL), dsDNA were used as template to the sequencing reaction. The BigDye terminator-cycle sequencing ready reaction (Perkin-Elmer) was used for the sequencing reaction. Briefly, the PCR was performed in a programmed thermal cycler (Gene Amp PCR System, mod. 2400, Perkin-Elmer) for 25 cycles, each consisting of denaturation at 96°C for 10 sec., annealing at 50°C for 5 sec. and polymerization at 60°C for 4 min. Following the sequencing reaction, DNA was purified according to the manufactures instructions of the Spin Columm-Centri-Sep P/N CS-901 (Princenton Separations). The product from the previous step was then dried in a speed-vacuum for 30 min. at 35°C, and the pellet was suspended with 10 ml of EDTA formamide buffer, heated for 2 min. at 95°C and immediately cooled on ice until the moment to be applied in the DNA ABI Prism mod. 310 (Perkinm Elmer Apllied biosystems).
The programs used for manipulation and alignment of the sequences were Sequencing Navigator, ClustalX, and Phylip. Canine (CPV-d, 15 and 39, respectively CPV types 2, 2a and 2b) and feline parvovirus sequences used as references to the alignment were obtained from the GenBank.
In this study we described the alignment of a 427 bp fragment of the VP1/VP2 gene from 21 CPV type 2b isolates. This selected region has two of the eight nucleotide differences among CPV antigenic types that resulted in coding changes in the coat protein. The first nucleotide substitution (4062 nt) is related to the residue 426, located at the top of the threefold spike, which is clearly involved with immunity escape and host range of the CPV. The other nucleotide change (4449 nt) is related to the residue 555 on a raise region within the two fold depression (6, 13) .
Overall we found a high degree of similarity among sequences from different CPV clinical isolates collected from 1990 to 1995. The alignment described here is in agreement with the published alignment and was also used to calculate a phylogenetic tree using the Fitch distance matrix method (Fig.  2) . As expected, the CPV viruses cluster closely together. Genetic analysis of this selected region gave no indication of a specific Brazilian parvovirus lineage.
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RESUMO
Diversidade genética no gene VP1/VP2 do parvovirus canino tipo 2b amplificado de material clínico no Brasil Neste estudo foi avaliada a diversidade genética no gene VP1/VP2 do parvovírus canino tipo 2b a partir de amostras isoladas de cães sintomáticos no Brasil. Foram estudadas 21 amostras coletadas no período de 1990 à 1995, previamente caracterizadas como CPV 2b pela técnica de PCR. Observou-se alto grau de similaridade entre as seqüências estudadas e a análise genética da região selecionada não indicou a presença de uma linhagem brasileira específica.
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